691 related articles for article (PubMed ID: 23301733)
1. JAKs and STATs in immunity, immunodeficiency, and cancer.
O'Shea JJ; Holland SM; Staudt LM
N Engl J Med; 2013 Jan; 368(2):161-70. PubMed ID: 23301733
[No Abstract] [Full Text] [Related]
2. Inborn errors of human JAKs and STATs.
Casanova JL; Holland SM; Notarangelo LD
Immunity; 2012 Apr; 36(4):515-28. PubMed ID: 22520845
[TBL] [Abstract][Full Text] [Related]
3. The JAK-STAT pathway: impact on human disease and therapeutic intervention.
O'Shea JJ; Schwartz DM; Villarino AV; Gadina M; McInnes IB; Laurence A
Annu Rev Med; 2015; 66():311-28. PubMed ID: 25587654
[TBL] [Abstract][Full Text] [Related]
4. Regulation of T cell homeostasis by JAKs and STATs.
Ross JA; Nagy ZS; Cheng H; Stepkowski SM; Kirken RA
Arch Immunol Ther Exp (Warsz); 2007; 55(4):231-45. PubMed ID: 17659375
[TBL] [Abstract][Full Text] [Related]
5. [Advances in study on drugs targeting the JAKs/STATs passway].
Sheng L; Li Y
Sheng Li Ke Xue Jin Zhan; 2006 Apr; 37(2):162-5. PubMed ID: 16850627
[No Abstract] [Full Text] [Related]
6. Inteferons pen the JAK-STAT pathway.
Schindler C; Plumlee C
Semin Cell Dev Biol; 2008 Aug; 19(4):311-8. PubMed ID: 18765289
[TBL] [Abstract][Full Text] [Related]
7. Targeting the interleukin-6/Jak/stat pathway in human malignancies.
Sansone P; Bromberg J
J Clin Oncol; 2012 Mar; 30(9):1005-14. PubMed ID: 22355058
[TBL] [Abstract][Full Text] [Related]
8. Cytokine receptor signaling through the Jak-Stat-Socs pathway in disease.
O'Sullivan LA; Liongue C; Lewis RS; Stephenson SE; Ward AC
Mol Immunol; 2007 Apr; 44(10):2497-506. PubMed ID: 17208301
[TBL] [Abstract][Full Text] [Related]
9. JAK/STAT disruption induces immuno-deficiency: Rationale for the development of JAK inhibitors as immunosuppressive drugs.
Cornez I; Yajnanarayana SP; Wolf AM; Wolf D
Mol Cell Endocrinol; 2017 Aug; 451():88-96. PubMed ID: 28131742
[TBL] [Abstract][Full Text] [Related]
10. Mining for JAK-STAT mutations in cancer.
Constantinescu SN; Girardot M; Pecquet C
Trends Biochem Sci; 2008 Mar; 33(3):122-31. PubMed ID: 18291658
[TBL] [Abstract][Full Text] [Related]
11. JAKs to STATs: A tantalizing therapeutic target in acute myeloid leukemia.
Venugopal S; Bar-Natan M; Mascarenhas JO
Blood Rev; 2020 Mar; 40():100634. PubMed ID: 31677846
[TBL] [Abstract][Full Text] [Related]
12. Janus kinase inhibitors: A therapeutic strategy for cancer and autoimmune diseases.
Hosseini A; Gharibi T; Marofi F; Javadian M; Babaloo Z; Baradaran B
J Cell Physiol; 2020 Sep; 235(9):5903-5924. PubMed ID: 32072644
[TBL] [Abstract][Full Text] [Related]
13. Emerging roles of JAK-STAT signaling pathways in adipocytes.
Richard AJ; Stephens JM
Trends Endocrinol Metab; 2011 Aug; 22(8):325-32. PubMed ID: 21561789
[TBL] [Abstract][Full Text] [Related]
14. Primary cytotoxic T-cell lymphomas harbor recurrent targetable alterations in the JAK-STAT pathway.
Lee K; Evans MG; Yang L; Ng S; Snowden C; Khodadoust M; Brown RA; Trum NA; Querfeld C; Doan LT; Song J; Zhang H; Gru AA; Wood GS; Wada DA; Shanmugam V; Haun PL; Aster JC; Duncan LM; Guitart J; Weinstock DM; Nardi V; Choi J
Blood; 2021 Dec; 138(23):2435-2440. PubMed ID: 34432866
[TBL] [Abstract][Full Text] [Related]
15. JAK/STAT Signal Transduction: Promising Attractive Targets for Immune, Inflammatory and Hematopoietic Diseases.
Gao Q; Liang X; Shaikh AS; Zang J; Xu W; Zhang Y
Curr Drug Targets; 2018; 19(5):487-500. PubMed ID: 27928945
[TBL] [Abstract][Full Text] [Related]
16. Mutated JAK kinases and deregulated STAT activity are potential therapeutic targets in cutaneous T-cell lymphoma.
Pérez C; González-Rincón J; Onaindia A; Almaráz C; García-Díaz N; Pisonero H; Curiel-Olmo S; Gómez S; Cereceda L; Madureira R; Hospital M; Suárez-Massa D; Rodriguez-Peralto JL; Postigo C; Leon-Castillo A; González-Vela C; Martinez N; Ortiz-Romero P; Sánchez-Beato M; Piris MÁ; Vaqué JP
Haematologica; 2015 Nov; 100(11):e450-3. PubMed ID: 26294736
[No Abstract] [Full Text] [Related]
17. Basic Science for the clinician 41: tails of cytokine receptor activation and control: JAKs, STATs, PIASs, and SOCSs.
Sigal LH
J Clin Rheumatol; 2006 Dec; 12(6):315-9. PubMed ID: 17149068
[TBL] [Abstract][Full Text] [Related]
18. The role of JAK/STAT signaling pathway and its inhibitors in diseases.
Xin P; Xu X; Deng C; Liu S; Wang Y; Zhou X; Ma H; Wei D; Sun S
Int Immunopharmacol; 2020 Mar; 80():106210. PubMed ID: 31972425
[TBL] [Abstract][Full Text] [Related]
19. Responses to Cytokines and Interferons that Depend upon JAKs and STATs.
Stark GR; Cheon H; Wang Y
Cold Spring Harb Perspect Biol; 2018 Jan; 10(1):. PubMed ID: 28620095
[TBL] [Abstract][Full Text] [Related]
20. SnapShot: Jak-STAT Signaling II.
Villarino AV; Gadina M; O'Shea JJ; Kanno Y
Cell; 2020 Jun; 181(7):1696-1696.e1. PubMed ID: 32589961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]